Combined Antioxidant and Glucocorticoid Therapy for Safer Treatment of Preterm Birth

Tessa A C Garrud1, Dino A Giussani1

  • 1Department of Physiology Development & Neuroscience, University of Cambridge, Cambridge, UK; Cambridge Cardiovascular Strategic Research Initiative, University of Cambridge, Cambridge, UK; Cambridge Strategic Research Initiative on Reproduction, University of Cambridge, Cambridge, UK.

Insights

Glucocorticoid therapy for preterm infants is effective but may cause harm. Combining it with antioxidants could offer a safer treatment option, reducing risks to infant growth and development.

Area of Science:

  • Neonatal medicine
  • Pharmacology
  • Developmental biology

Background:

  • Ante- and postnatal glucocorticoid therapy is a successful clinical translation of basic science, significantly reducing preterm infant morbidity and mortality.
  • However, concerns exist regarding potential long-term adverse effects on offspring growth, neurological, and cardiovascular function.
  • Evidence stems from human clinical and animal model studies.

Purpose of the Study:

  • To explore the potential benefits and safety of combined antioxidant and glucocorticoid therapy compared to glucocorticoid therapy alone for preterm infants.
  • To review existing evidence on the long-term effects of glucocorticoid treatment in preterm neonates.

Main Methods:

  • Literature review of human clinical studies.
  • Literature review of experimental studies in animal models.
  • Analysis of evidence regarding combined antioxidant and glucocorticoid therapy.

Main Results:

  • Glucocorticoid therapy demonstrates efficacy in reducing immediate preterm infant complications.
  • Significant concerns are raised about potential long-term adverse outcomes associated with glucocorticoid use.
  • The review investigates the safety profile of adding antioxidants to glucocorticoid regimens.

Conclusions:

  • Combined antioxidant and glucocorticoid therapy may represent a safer alternative to glucocorticoid monotherapy for preterm infants.
  • Further research is warranted to confirm the safety and efficacy of this combined approach.
  • Mitigating long-term adverse effects is a critical consideration in neonatal care for preterm infants.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
476
Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
6.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
611
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K